2020 Virtual Fall Networks Conference - Ideation to H2 Opportunity Portfolio

We continue to make timely and substantial progress on the iHOPe Project. We completed Phase 1: Define the Challenges for Horizon 2. Our findings are that despite available funding, many companies struggle to achieve confidence in making decisions about which Opportunities to select and which to abandon. Now, we’re in Phase 2: Document Current H2 Activities and Practices. During Phase 2 we will be interviewing select companies about their Horizon 2 activities and decision-making – we are continuing to seek interview candidates. Dr. Richard Sonnenblick, one of the foremost authorities in pharma and biotech portfolio management, will review the activities and tools used most successfully by drug development organizations for refining and executing projects in the awkward middle stages of development.

Logged in IRI members can watch the recording here: https://www.pathlms.com/iri-learningcenter/events/485/event_sections/119...